Skip to search formSkip to main contentSkip to account menu

Sch 42427

Known as: Sch-42427 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Sch 39304

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Relationship Among Physicochemical Properties, Skin Permeability, and Topical Activity of the Racemic Compound and Pure Enantiomers of a New Antifungal
The topical antifungal Sch-39304 is a racemic compound comprised of two enantiomers, Sch-42427 and Sch-42426, only one of which… 
1993
1993
Effect of anti‐IL‐4, interferon‐gamma and an antifungal triazole (SCH 42427) in paracoccidioidomycosis: correlation of IgE levels with outcome
Paracoccidioidomycosis is characterized by depressed cellular but enhanced humoral immune responses, which suggests a Th2 type of… 
1992
1992
In vitro and in vivo activities of SCH 42427, the active enantiomer of the antifungal agent SCH 39304
SCH 39304, a new triazole antifungal agent, is a 50:50 racemic mixture of two enantiomers, SCH 42427 and SCH 42426. The… 
1992
1992
Comparison of SCH 39304 and its isomers, RR 42427 and SS 42426, for treatment of murine cryptococcal and coccidioidal meningitis
SCH 39304 (304) and its isomers, SCH 42426 (426) and SCH 42427 (427), are new orally administered antifungal azole derivatives… 
Review
1992
Review
1992
Experimental antifungal chemotherapy in granulocytopenic animal models of disseminated candidiasis: approaches to understanding investigational antifungal compounds for patients with neoplastic…
Disseminated candidiasis is the most common life-threatening invasive fungal infection in granulocytopenic patients. A review of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)